https://www.selleckchem.com/pr....oducts/pemigatinib-i
Patient enrollment began in May 2018 and to date, 244 patients have been enrolled. Adhering to strict enrollment criteria, competency modules and review of patient status provided a solid core for the program and process review. Successful implementation of an NG Bridle program was achieved. Outcomes of interest continue to be monitored for process improvement. Balancing measures are also being tracked for potential downstream effects. Spontaneous rupture of the urinary bladder is rare but potentially severe. It is unusua
Curtir
Comentario
Compartilhar
